Skip to content
★ Sign in to follow
MA
Total declarations
64
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (11 ops.)
€3.2M

Latest filing published 02 Jul 2020 for AtriCure, Inc., €9,107.

Filing timeline

BuySale
M. Andrew Wade

Insider track record

Disclosed buys
0
Disclosed sells
11
Signal history

M. Andrew Wade: trading record in brief

M. Andrew Wade discloses dealings in AtriCure, Inc. to SEC (Form 4). The record holds 64 filings, for trades running from 27 December 2012 to 30 June 2020.

Sales make up the whole of the open-market record (11 sales, €3.2M). Besides market trades, the filings include 45 share grants and 8 option exercises. 2020 to date brings no purchases and 5 sales.

The latest filing, published on 2 July 2020, reports a share grant of €9,107 in AtriCure, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to M. Andrew Wade

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations62 total
  • ◆
    CFOExecutivesAtriCure, Inc.
    10,232 USD19SEC
    364 shares@ US$28.110.3% of flowCommon StockSEC:0001209191-20-040404:0
  • ◆
    CFOExecutivesAtriCure, Inc.
    627,552 USD21SEC
    16,334 shares@ US$38.4215.8% of flowCommon StockSEC:0001209191-20-015100:1
  • ◆
    CFOExecutivesAtriCure, Inc.
    0SEC
    11,387 shares0Common StockSEC:0001209191-20-015100:0
  • ◇
    CFOExecutivesAtriCure, Inc.
    100,950 USD19SEC
    15,000 shares@ US$6.732.6% of flowCommon StockSEC:0001209191-20-011855:2
  • ▼
    CFOExecutivesAtriCure, Inc.
    591,900 USD33SEC
    15,000 shares@ US$39.4615.2% of flowCommon StockSEC:0001209191-20-011855:3
  • ◇
    CFOExecutivesAtriCure, Inc.
    94,050 USD19SEC
    15,000 shares@ US$6.272.4% of flowCommon StockSEC:0001209191-20-011855:0
  • ▼
    CFOExecutivesAtriCure, Inc.
    591,750 USD33SEC
    15,000 shares@ US$39.4515.2% of flowCommon StockSEC:0001209191-20-011855:1
  • ◇
    SVP and CFOExecutivesAtriCure, Inc.
    62,700 USD19SEC
    10,000 shares@ US$6.271.4% of flowCommon StockSEC:0001209191-20-003794:0
  • ▼
    SVP and CFOExecutivesAtriCure, Inc.
    360,000 USD38SEC
    10,000 shares@ US$36.007.9% of flowCommon StockSEC:0001209191-20-003794:1
  • ◇
    SVP and CFOExecutivesAtriCure, Inc.
    62,700 USD19SEC
    10,000 shares@ US$6.271.4% of flowCommon StockSEC:0001209191-20-003571:0
  • ▼
    SVP and CFOExecutivesAtriCure, Inc.
    340,000 USD38SEC
    10,000 shares@ US$34.007.4% of flowCommon StockSEC:0001209191-20-003571:1
  • ◆
    SVP and CFOExecutivesAtriCure, Inc.
    10,526 USD19SEC
    405 shares@ US$25.990.2% of flowCommon StockSEC:0001209191-20-000816:0
  • ◇
    SVP and CFOExecutivesAtriCure, Inc.
    11,200 USD19SEC
    1,000 shares@ US$11.200.2% of flowCommon StockSEC:0001209191-19-062055:0
  • ▼
    SVP and CFOExecutivesAtriCure, Inc.
    32,000 USD31SEC
    1,000 shares@ US$32.000.7% of flowCommon StockSEC:0001209191-19-062055:1
  • ▼
    SVP and CFOExecutivesAtriCure, Inc.
    351,150 USD20SEC
    11,705 shares@ US$30.007.8% of flowCommon StockSEC:0001209191-19-058142:0
  • ◆
    SVP and CFOExecutivesAtriCure, Inc.
    10,322 USD19SEC
    407 shares@ US$25.360.2% of flowCommon StockSEC:0001209191-19-040615:0
  • ▼
    SVP and CFOExecutivesAtriCure, Inc.
    21,120 USD19SEC
    704 shares@ US$30.000.5% of flowCommon StockSEC:0001209191-19-034969:0
  • ▼
    SVP and CFOExecutivesAtriCure, Inc.
    303,210 USD20SEC
    10,107 shares@ US$30.006.6% of flowCommon StockSEC:0001209191-19-034969:1
  • ▼
    SVP and CFOExecutivesAtriCure, Inc.
    295,500 USD32SEC
    9,850 shares@ US$30.006.4% of flowCommon StockSEC:0001209191-19-026695:0
  • ◆
    SVP and CFOExecutivesAtriCure, Inc.
    0SEC
    15,437 shares0Common StockSEC:0001209191-19-017221:0
  • ◆
    SVP and CFOExecutivesAtriCure, Inc.
    632,324 USD20SEC
    20,550 shares@ US$30.7713.4% of flowCommon StockSEC:0001209191-19-017221:1
  • ◇
    SVP and CFOExecutivesAtriCure, Inc.
    1,500 USD19SEC
    1,000 shares@ US$1.500.0% of flowCommon StockSEC:0001209191-19-005508:0
  • ◆
    SVP and CFOExecutivesAtriCure, Inc.
    10,008 USD19SEC
    417 shares@ US$24.000.2% of flowCommon StockSEC:0001209191-19-000622:0
  • ◆
    SVP and CFOExecutivesAtriCure, Inc.
    9,624 USD19SEC
    613 shares@ US$15.700.2% of flowCommon StockSEC:0001209191-18-041217:0
  • ◆
    SVP and CFOExecutivesAtriCure, Inc.
    0SEC
    35,996 shares0Common StockSEC:0001209191-18-016462:0

25 of 62 declarations